Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice

<p>Abstract</p> <p>Background</p> <p>To conserve laryngeal function and elevate living quality of laryngeal squamous cell carcinoma (LSCC) patients, we designed antisense oligodeoxynucleotides (AS-ODNs) to reduce expression of ATM and to enhance the apoptosis of hep-2 (...

Full description

Bibliographic Details
Main Authors: Zhao Yongsheng, Li Li, Zou Jian, Feng Jun, Liu Shixi
Format: Article
Language:English
Published: BMC 2011-04-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
ATM
Online Access:http://www.jeccr.com/content/30/1/43
id doaj-4ec2b709228f45ab9088eb6465230d9a
record_format Article
spelling doaj-4ec2b709228f45ab9088eb6465230d9a2020-11-24T23:55:59ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662011-04-013014310.1186/1756-9966-30-43Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude miceZhao YongshengLi LiZou JianFeng JunLiu Shixi<p>Abstract</p> <p>Background</p> <p>To conserve laryngeal function and elevate living quality of laryngeal squamous cell carcinoma (LSCC) patients, we designed antisense oligodeoxynucleotides (AS-ODNs) to reduce expression of ATM and to enhance the apoptosis of hep-2 (Human epidermoid laryngeal carcinoma) cells to radiation in vitro and in vivo.</p> <p>Methods</p> <p>The expression of ATM mRNA and protein in hep-2 cells were examined by real-time quantitative PCR and western blotting respectively. Clonogenic survival assay was carried out to detect the survival ability of hep-2 cells after irradiation, and analyzed the cell apoptosis by flow cytometry. The volume of solid tumors was measured, while TUNEL assay and western blotting used to analyze cell apoptosis and protein expression after irradiation.</p> <p>Results</p> <p>The relative ATM mRNA and protein expression in hep-2 cells treated with ATM AS-ODNs were decreased to 11.03 ± 2.51% and 48.14 ± 5.53% of that in untreated cells respectively (P <0.05). After irradiation, the survival fraction (SF) of cells treated with ATM AS-ODNs was lower than that of other groups at the same dose of radiation (P < 0.05). The inhibition rate in hep-2 cells solid tumor exposed to X-ray alone was 5.95 ± 4.52%, while it was 34.28 ± 2.43% in the group which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The apoptotic index for the group irradiated in combination with ATM AS-ODNs injection was 17.12 ± 4.2%, which was significantly higher than that of others (P < 0.05).</p> <p>Conclusion</p> <p>AS-ODNs of ATM reduce ATM expression and enhance hep-2 cells apoptosis to radiation in vitro and in vivo.</p> http://www.jeccr.com/content/30/1/43ATMAntisense oligodeoxynucleotidesapoptosissquamous cell carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Zhao Yongsheng
Li Li
Zou Jian
Feng Jun
Liu Shixi
spellingShingle Zhao Yongsheng
Li Li
Zou Jian
Feng Jun
Liu Shixi
Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
Journal of Experimental & Clinical Cancer Research
ATM
Antisense oligodeoxynucleotides
apoptosis
squamous cell carcinoma
author_facet Zhao Yongsheng
Li Li
Zou Jian
Feng Jun
Liu Shixi
author_sort Zhao Yongsheng
title Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
title_short Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
title_full Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
title_fullStr Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
title_full_unstemmed Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
title_sort antisense oligodeoxynucleotides targeting atm strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2011-04-01
description <p>Abstract</p> <p>Background</p> <p>To conserve laryngeal function and elevate living quality of laryngeal squamous cell carcinoma (LSCC) patients, we designed antisense oligodeoxynucleotides (AS-ODNs) to reduce expression of ATM and to enhance the apoptosis of hep-2 (Human epidermoid laryngeal carcinoma) cells to radiation in vitro and in vivo.</p> <p>Methods</p> <p>The expression of ATM mRNA and protein in hep-2 cells were examined by real-time quantitative PCR and western blotting respectively. Clonogenic survival assay was carried out to detect the survival ability of hep-2 cells after irradiation, and analyzed the cell apoptosis by flow cytometry. The volume of solid tumors was measured, while TUNEL assay and western blotting used to analyze cell apoptosis and protein expression after irradiation.</p> <p>Results</p> <p>The relative ATM mRNA and protein expression in hep-2 cells treated with ATM AS-ODNs were decreased to 11.03 ± 2.51% and 48.14 ± 5.53% of that in untreated cells respectively (P <0.05). After irradiation, the survival fraction (SF) of cells treated with ATM AS-ODNs was lower than that of other groups at the same dose of radiation (P < 0.05). The inhibition rate in hep-2 cells solid tumor exposed to X-ray alone was 5.95 ± 4.52%, while it was 34.28 ± 2.43% in the group which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The apoptotic index for the group irradiated in combination with ATM AS-ODNs injection was 17.12 ± 4.2%, which was significantly higher than that of others (P < 0.05).</p> <p>Conclusion</p> <p>AS-ODNs of ATM reduce ATM expression and enhance hep-2 cells apoptosis to radiation in vitro and in vivo.</p>
topic ATM
Antisense oligodeoxynucleotides
apoptosis
squamous cell carcinoma
url http://www.jeccr.com/content/30/1/43
work_keys_str_mv AT zhaoyongsheng antisenseoligodeoxynucleotidestargetingatmstrengthenapoptosisoflaryngealsquamouscellcarcinomagrowninnudemice
AT lili antisenseoligodeoxynucleotidestargetingatmstrengthenapoptosisoflaryngealsquamouscellcarcinomagrowninnudemice
AT zoujian antisenseoligodeoxynucleotidestargetingatmstrengthenapoptosisoflaryngealsquamouscellcarcinomagrowninnudemice
AT fengjun antisenseoligodeoxynucleotidestargetingatmstrengthenapoptosisoflaryngealsquamouscellcarcinomagrowninnudemice
AT liushixi antisenseoligodeoxynucleotidestargetingatmstrengthenapoptosisoflaryngealsquamouscellcarcinomagrowninnudemice
_version_ 1725460235748900864